ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
1.740
+0.170 (10.83%)
At close: Jan 30, 2026, 4:00 PM EST
1.710
-0.030 (-1.72%)
After-hours: Jan 30, 2026, 7:58 PM EST
ALX Oncology Holdings Market Cap
ALX Oncology Holdings has a market cap or net worth of $94.34 million as of January 30, 2026. Its market cap has increased by 9.73% in one year.
Market Cap
94.34M
Enterprise Value
49.32M
1-Year Change
9.73%
Ranking
Category
Stock Price
$1.74
Market Cap Chart
Since July 17, 2020, ALX Oncology Holdings's market cap has decreased from $1.06B to $94.34M, a decrease of -91.07%. That is a compound annual growth rate of -35.33%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 94.34M | 53.98% |
| Dec 31, 2025 | 61.27M | -30.44% |
| Dec 31, 2024 | 88.08M | -88.13% |
| Dec 29, 2023 | 741.80M | 61.50% |
| Dec 30, 2022 | 459.31M | -47.23% |
| Dec 31, 2021 | 870.34M | -74.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Anixa Biosciences | 101.47M |
| Coya Therapeutics | 97.30M |
| Agenus | 96.58M |
| Cognition Therapeutics | 96.22M |
| Fortress Biotech | 96.22M |
| Cassava Sciences | 96.13M |
| Artiva Biotherapeutics | 95.48M |
| Precision BioSciences | 95.32M |